PharmaCyte Biotech Inc (PMCB)

[ace1234]

Possibly good news?

So Ive been reading up on price to book ratio and our price to book ratio increases:

Assumed offering price per share $ 0.071
Net tangible book value per share $ 0.004
Increase in net tangible book value per share attributable to the offering $ 0.017
As-adjusted net tangible book value per share after giving effect to the offering $ 0.021
Dilution in net tangible book value per share to new investors $ 0.050



So from a ration of .057/.004= 14.25

to a ratio of .057/.021= 2.71

In essence, while still generally overpriced based on this ratio its nearly 3 times closer to the actual valuation of PMCB.

Someone correct me if I'm wrong in my understanding here.